A detailed history of Clearbridge Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,843,004 shares of ABBV stock, worth $481 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
2,843,004
Previous 3,847,664 26.11%
Holding current value
$481 Million
Previous $660 Million 14.93%
% of portfolio
0.46%
Previous 0.55%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $165 Million - $200 Million
-1,004,660 Reduced 26.11%
2,843,004 $561 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $47.5 Million - $55.5 Million
-307,104 Reduced 7.39%
3,847,664 $660 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $33.9 Million - $38.6 Million
212,149 Added 5.38%
4,154,768 $757 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $30 Million - $33.8 Million
217,817 Added 5.85%
3,942,619 $611 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $27.9 Million - $32.3 Million
208,675 Added 5.93%
3,724,802 $555 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $17.8 Million - $22.2 Million
134,425 Added 3.98%
3,516,127 $474 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $10.5 Million - $12.1 Million
72,938 Added 2.2%
3,381,702 $539 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $16.3 Million - $19.5 Million
-117,859 Reduced 3.44%
3,308,764 $535 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $11 Million - $12.6 Million
81,670 Added 2.44%
3,426,623 $460 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $17.5 Million - $22.2 Million
-126,973 Reduced 3.66%
3,344,953 $512 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $46 Million - $57.1 Million
-348,470 Reduced 9.12%
3,471,926 $563 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $3.93 Million - $4.97 Million
-36,597 Reduced 0.95%
3,820,396 $517 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $21.1 Million - $23.9 Million
-197,991 Reduced 4.88%
3,856,993 $416 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $11.2 Million - $12.5 Million
-106,236 Reduced 2.55%
4,054,984 $457 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $9.72 Million - $10.7 Million
-94,967 Reduced 2.23%
4,161,220 $450 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $11 Million - $14.9 Million
-136,839 Reduced 3.11%
4,256,187 $456 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $10.2 Million - $12 Million
118,936 Added 2.78%
4,393,026 $385 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $256 Million - $342 Million
3,483,416 Added 440.56%
4,274,090 $420 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $12.9 Million - $19.6 Million
200,714 Added 34.02%
790,674 $60.2 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $41.7 Million - $52.1 Million
577,835 Added 4765.65%
589,960 $52.8 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $11,651 - $14,008
185 Added 1.55%
12,125 $918,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $30,616 - $39,134
466 Added 4.06%
11,940 $0
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $115,710 - $136,185
-1,500 Reduced 11.56%
11,474 $925,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $77,850 - $96,010
1,000 Added 8.35%
12,974 $1.2 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $160,038 - $177,912
-1,800 Reduced 13.07%
11,974 $1.13 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $718 - $849
-8 Reduced 0.06%
13,774 $1.28 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $87,133 - $116,679
947 Added 7.38%
13,782 $1.3 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $395,138 - $433,302
4,412 Added 52.38%
12,835 $1.24 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $22,631 - $28,907
-324 Reduced 3.7%
8,423 $748,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,747
8,747 $634,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.